Welcome to our dedicated page for Allied Motion SEC filings (Ticker: ALNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Allient Inc. (Nasdaq: ALNT) SEC filings page on Stock Titan is intended to bring together the company’s regulatory disclosures once they are available from the U.S. Securities and Exchange Commission’s EDGAR system. Allient is a global engineering and manufacturing enterprise that develops precision and specialty Motion, Controls and Power products and solutions for targeted industries and applications, including medical, life sciences, aerospace and defense, industrial automation, robotics, semiconductor, transportation, agriculture, construction and facility infrastructure.
For a company with this profile, core SEC filings such as annual reports on Form 10‑K and quarterly reports on Form 10‑Q typically provide detailed information on segment performance across markets like Industrial, Medical, Vehicle, and Aerospace & Defense, as well as discussions of demand drivers such as power quality solutions for HVAC and data center infrastructure, defense and space program deliveries, and selected medical applications. Other filings, including Form 8‑K, often summarize earnings releases, dividend declarations, strategic initiatives and significant events affecting the business.
As these documents become available, Stock Titan’s platform can surface them alongside AI‑powered summaries that explain key points in accessible language. This can help readers quickly interpret disclosures related to revenue trends, gross margin and operating margin commentary, cash flow, leverage ratios, and management’s discussion of macro factors such as tariff developments and rare earth material trade constraints. For those monitoring governance and ownership, forms related to insider activity, such as Form 4, and proxy materials on Schedule 14A are also relevant.
Although no specific SEC filings are listed in the current data set, this page is designed to update as new Allient filings are posted to EDGAR. Users can then review the full text of each filing together with AI‑generated highlights to better understand how Allient’s Motion, Controls and Power technologies, financial performance, capital structure and risk factors are described in its official regulatory reports.
Allient Inc. reporting person Kenneth A. May, Chief Technology Officer, disclosed a withholding transaction on 09/01/2025 in connection with vested restricted stock. The company withheld 207 shares of Common Stock at a reported price of $45.38 to satisfy tax withholding obligations under the shareholder-approved stock incentive plan. After the withholding, Mr. May beneficially owned 17,465 shares directly and 1,049 shares indirectly through an ESOP trust. The Form 4 was signed by attorney-in-fact Michael C. Donlon on 09/03/2025.
James A. Michaud, Chief Financial Officer of Allient Inc. (ALNT), reported a transaction on Form 4 dated 08/07/2025 showing he instructed the company to withhold shares to satisfy tax withholding obligations upon the vesting of restricted stock under the company's shareholder-approved stock incentive plan.
The filing shows 972 shares were withheld and a price of $42.29 is shown on the form. After the withholding, the report lists 9,978 shares beneficially owned by Mr. Michaud as direct ownership. The Form 4 was signed on behalf of Mr. Michaud by an attorney-in-fact, Michael C. Donlon, on 08/11/2025.
Allient Inc. (ALNT) – Form 4 insider filing: Non-employee director Steven C. Finch received 597 shares of ALNT common stock on 6 Aug 2025. The shares were issued as quarterly retainer compensation under the company’s 2017 Omnibus Incentive Plan, not through an open-market purchase. The transaction is coded “A” (acquisition) and priced at $39.79 per share, implying stock compensation worth roughly $23,700. Following the grant, Finch’s total direct beneficial ownership rises to 12,188 shares.
The filing indicates routine board compensation rather than a discretionary buy; nevertheless, it modestly increases director equity alignment. No derivative securities were involved and no other officers or insiders are referenced.